 Brokerages expect that Crinetics Pharmaceuticals Inc NASDAQ:CRNX will report earnings of 0.63 per share for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Crinetics Pharmaceuticals earnings, with estimates ranging from 0.70 to 0.60. Crinetics Pharmaceuticals posted earnings of 0.37 per share in the same quarter last year, which would indicate ... 